• Illumina
  •  Overview
  • Last Modified:
  • July 16, 2025
  • Company type:
  • Public
  • Industry:
  • Manufacturing
  • Verified:
  • No
  • No of Employees:
  • 1 001 - 10 000
  • Stock Code:
  • ILMN
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • San Diego, California
  • Public Interest Score:
  • 750+

 

  • Illumina
  • General Information

Description

Illumina is a global leader in genomics and biotechnology, specializing in DNA sequencing and array-based technologies. They develop and manufacture tools for analyzing genetic variation and biological function, with applications in research, clinical diagnostics, and applied markets. Illumina’s products and services play a significant role in advancing fields like oncology, genetic and infectious diseases, and reproductive health. 

Here’s a more detailed breakdown:
  • Core Business: Illumina focuses on developing and providing the tools necessary for DNA sequencing and array-based technologies. 
  • Applications: Their products are used in various fields, including:
    • Genomics Research: Understanding the human genome and its variations. 
    • Clinical Diagnostics: Identifying genetic predispositions to diseases and aiding in diagnosis. 
    • Oncology: Developing cancer treatments and diagnostics based on genetic mutations. 
    • Reproductive Health: Enabling prenatal testing and genetic counseling. 
    • Infectious Disease Research: Studying pathogens and developing diagnostic tools. 
    • Applied Markets: Including agriculture and other emerging areas. 
  • Key Technologies: Illumina’s technologies include:
    • Next-Generation Sequencing (NGS): A high-throughput method for rapidly sequencing DNA. 
    • Microarrays: Used for analyzing genetic variations and gene expression. 
    • Sequencing by Synthesis (SBS): A scalable NGS technology. 
  • Global Reach: Illumina serves customers in over 155 countries. 
  • Headquarters: The company is headquartered in San Diego, California. 
  • History: Illumina was founded in 1998. 
Stephen Macmillan:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jacob Thaysen:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frances Arnold:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Caroline Dorsa:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Robert Epstein:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: Yes, qsix: No
Scott Gottlieb:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Gary Guthart:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Philip Schiller:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sue Siegel:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Andrew Teno:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Scott Ullem:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 15235
  • Founded Year: 
  • 1998
  • Registration Number: 
  • 33-0804655
  • Country: 
  • United States of America
  • Stock Exchanges: 
    • NASDAQ Stock Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 150
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Health Care Devices
  • Date listed on Stock Exchange: 
  • 28/07/2000

 

  • Contact Information
  • Business operation: 
  • We believe the genome has the potential to solve humanity’s biggest problems. This belief inspires us to relentlessly push the boundaries of what is possible today—to enable researchers and clinicians to turn big dreams into impactful genomic discoveries that improve lives and change the course of diseases globally.
  • Primary office: 
  • 5200 Illumina Way (formerly 5200 Research Pl) San Diego, CA 92122 USA.

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Gwen Chapman
  • Reporting currency: 
  • USD
  • ISIN number (12 digit): 
NASDAQ
US4523271090
  • Authorised shares:
  • 320 000 000
  • Issued shares:
  • 200 000 000
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Fitch Ratings Credit LogoUnited States of AmericaNew YorkBBB

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Stephen P

Executive
NationalityAmerican
61
RoleChairman, President, CEO
QualificationBEcon, AMP
Date Appointed: 01/06/2023
Duration:
3 years and 3 months
Independance: Y
Profile
Name

Jacob

Executive
NationalityAmerican
51
RoleVP,CEO
QualificationM.Sc.,Ph.D.
Date Appointed: 01/09/2023
Duration:
3 years and 0 month
Independance: Y
Profile
Name

Frances

Non Executive
NationalityAmerican
70
RoleNED
QualificationPhD,BSE
Date Appointed: 01/01/2016
Duration:
10 years and 8 months
Independance: N
Profile
Name

Caroline

Non Executive
NationalityAmerican
67
RoleNED
QualificationMBA,BA
Date Appointed: 01/01/2017
Duration:
9 years and 8 months
Independance: Y
Profile
Name

Robert

Non Executive
NationalityAmerican
71
RoleNED
QualificationM.D
Date Appointed: 01/11/2012
Duration:
13 years and 10 months
Independance: N
Profile
Name

Scott

Executive
NationalityAmerican
54
RoleDirector
QualificationM.D,BScEcon
Date Appointed: 01/02/2020
Duration:
6 years and 7 months
Independance: Y
Profile
Name

Gary S.

Executive
NationalityAmerican
56
RoleCEO
QualificationBS,MS,PhD
Date Appointed: 01/12/2017
Duration:
8 years and 9 months
Independance: Y
Profile
Name

Philip

Non Executive
NationalityAmerican
66
RoleNED
QualificationBSbio
Date Appointed: 01/07/2016
Duration:
10 years and 2 months
Independance: N
Profile
Name

Sue

Non Executive
NationalityAmerican
RoleNED
QualificationBSbio, MSbio
Date Appointed: 01/02/2019
Duration:
7 years and 7 months
Independance: Y
Profile
Name

Andrew

Non Executive
NationalityAmerican
42
RoleNED
QualificationNot Available
Date Appointed: 01/05/2023
Duration:
3 years and 4 months
Independance: Y
Profile
Name

Scott

Non Executive
NationalityAmerican
59
RoleNED
QualificationMBA,BS
Date Appointed: 01/01/2023
Duration:
3 years and 8 months
Independance: Y
Profile

 

Directors Tenure

Name
Duration
Name

Stephen P Macmillan

Duration3 years and 3 months
Profile
Name

Jacob Thaysen

Duration3 years and 0 month
Profile
Name

Frances Arnold

Duration10 years and 8 months
Profile
Name

Caroline Dorsa

Duration9 years and 8 months
Profile
Name

Robert Epstein

Duration13 years and 10 months
Profile
Name

Scott Gottlieb

Duration6 years and 7 months
Profile
Name

Gary S. Guthart

Duration8 years and 9 months
Profile
Name

Philip Schiller

Duration10 years and 2 months
Profile
Name

Sue Siegel

Duration7 years and 7 months
Profile
Name

Andrew Teno

Duration3 years and 4 months
Profile
Name

Scott Ullem

Duration3 years and 8 months
Profile

 

Director Experience

Name
Experience
Name

Stephen P

Experience Other, Pharmaceutical
Profile
Name

Jacob

Experience Healthcare
Profile
Name

Frances

Experience Healthcare
Profile
Name

Caroline

Experience Energy, Healthcare
Profile
Name

Robert

Experience Healthcare, Engineering, Business Services
Profile
Name

Scott

Experience Healthcare, Financial Services
Profile
Name

Gary S.

Experience Healthcare, Engineering, Business Services
Profile
Name

Philip

Experience Technology, Healthcare
Profile
Name

Sue

Experience Technology, Investment, Healthcare
Profile
Name

Andrew

Experience Financial Services, Investment
Profile
Name

Scott

Experience Healthcare, Financial Services
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

Ernst & Young

Date Appointed01/01/2000
Year26 years and 8 months
Profile

 

 

Company Committees

Name

Frances Arnold

Mainboard, Audit, Remuneration BD, NG, TE
Profile
Name

Caroline Dorsa

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Robert Epstein

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Scott Gottlieb

Mainboard, Audit, Remuneration BD, RE, NG
Profile
Name

Gary S. Guthart

Mainboard, Audit, Remuneration BD, AU, TE
Profile
Name

Stephen P Macmillan

Mainboard, Audit, Remuneration BD
Profile
Name

Philip Schiller

Mainboard, Audit, Remuneration BD, NG, TE
Profile
Name

Sue Siegel

Mainboard, Audit, Remuneration BD, RE
Profile
Name

Andrew Teno

Mainboard, Audit, Remuneration BD, RE
Profile
Name

Jacob Thaysen

Mainboard, Audit, Remuneration BD
Profile
Name

Scott Ullem

Mainboard, Audit, Remuneration BD, AU
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT